Low Back Pain
Conditions
Keywords
Low Back Pain
Brief summary
Objective To demonstrate the effectiveness of a conservative treatment approach for chronic low back pain that addresses the underlying problem of intervertebral disc lesions and degenerative disc disease, namely vertebral pressure on vital structures of the lumbar region.
Detailed description
Low back pain (LBP) is a common medical problem and a challenging condition to treat. This study will investigate the effectiveness of a conservative treatment approach for chronic LBP. To this point few treatment approaches specifically address the resolution of underlying pathologies leading to a high probability of recurrence of LBP. Further, current treatment options for lumbar disc pathology have been of limited demonstrated effectiveness. The purpose of this study is to determine whether a non-surgical therapeutic approach designed to effect intervertebral widening and allow for reduction of disc protrusion will reduce patients' pain and improve their activity levels. The study will assess whether a computer-assisted traction treatment \[decompression\] protocol results in improvement in patient pain levels and daily activity levels. Further, to determine if such treatment results in intervertebral widening and reduction of any disc protrusions as demonstrated by direct imaging of the lumbar spine. A double-blind (treatment vs. sham treatment) design will be employed Specific Aims To study the effectiveness of decompression therapy for LBP patients with lumbar disc herniation and degenerative disc problems. To demonstrate that decompression therapy for LBP patients results in a demonstrated reduction in levels of reported pain. To demonstrate that decompression therapy for LBP patients results in a demonstrated greater return to daily activities. To demonstrate that decompression therapy for LBP patients results in increased intervertebral space and reduced disk protrusion (if present) as measured by MRI.
Interventions
DEVICESpineMed Table, Cert HealthSciences LLC
For Group A (the treated group) the following tension adjustments will be used: starting treatment tension will equal 1/4 body weight minus 10 lbs. Incremental increases of 4 lbs. per session will be implemented until optimum tensions are reached, which would be a maximum of ¼ body weight plus 25 lbs, unless distraction tensions cause discomfort, which would require a reduction of the tensions applied.
Sponsors
State University of New York - Upstate Medical University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Non-specific LBP of at least 6 weeks duration with no evidence of underlying disease or anatomic abnormalities, * Applicants may have pain radiating to their legs.
Exclusion criteria
* Any episode of Acute LBP within the last 6 weeks or less * Recent Fractures, less than 8 weeks of any bone * Tumors of any type including soft tissue tumors, myeloma, malignant or documented tumors of any type * Gross osteoporosis, * Spondylolisthesis grade 2 and above, * Hardware fixation, spine fixation or other boney fusion * Obesity as defined by a BMI greater than 35, body weight over 287 pounds, * Contra-indication for MRJ assessment, * Pregnancy, * neurologic deficits, * bowel or bladder incontinence, * progressive lower extremity weakness, * need for narcotic pain medications for other conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional activity will be measured using the Roland Morris activity scale | 19 weeks |
| MRI outcome measures include thickness of disc (disc height, intervertebral space), extent of disc bulging, intervertebral alignment. | 19 weeks |
| Pain will be measured using a 0-100 visual analog scale. | 19 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Treatment satisfaction will be measured using a 5-point Likert scale. | 19 weeks |
| Physical and social activities and quality of life will be measured with the COOP | 19 weeks |
| Reduction in pain medication usage | 19 weeks |
| Functional health will be measured with the SF-36 | 19 weeks |
| Depression will be measured using the Geriatric Depression Scale (GDS) | 19 weeks |
Countries
United States
Outcome results
None listed